First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Down 74.2% in June

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 8,067 shares, a decline of 74.2% from the June 15th total of 31,278 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily volume of 116,884 shares, the short-interest ratio is presently 0.1 days.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 0.8%

Shares of NYSEARCA FBT traded down $2.05 during midday trading on Monday, reaching $247.54. The company had a trading volume of 28,241 shares, compared to its average volume of 127,664. The business’s 50-day simple moving average is $226.32 and its 200 day simple moving average is $213.70. The stock has a market cap of $2.78 billion, a P/E ratio of 21.72 and a beta of 0.65. First Trust NYSE Arca Biotechnology Index Fund has a 1 year low of $158.92 and a 1 year high of $258.20.

Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. First Trust Advisors LP lifted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 0.8% during the second quarter. First Trust Advisors LP now owns 8,393 shares of the company’s stock worth $1,355,000 after purchasing an additional 66 shares during the period. Baird Financial Group Inc. increased its holdings in First Trust NYSE Arca Biotechnology Index Fund by 12.9% in the 2nd quarter. Baird Financial Group Inc. now owns 8,039 shares of the company’s stock worth $1,297,000 after buying an additional 916 shares during the period. Benjamin Edwards Inc. lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 40.5% during the 2nd quarter. Benjamin Edwards Inc. now owns 28,808 shares of the company’s stock valued at $4,648,000 after acquiring an additional 8,304 shares during the period. Two Sigma Securities LLC boosted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 56.5% in the 2nd quarter. Two Sigma Securities LLC now owns 2,001 shares of the company’s stock valued at $323,000 after acquiring an additional 722 shares during the last quarter. Finally, Corient Private Wealth LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the second quarter worth $692,000.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.